StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
2465.TW$89.10+0.68%
Fair $89.10+0.0%

2465.TW

Leadtek Research Inc.

Technology / Computer HardwareTaiwan

$89.10

+0.60 (+0.68%)

Fairly Valued+0.0%Fair Value $89.10Fund rank 28/100 · Data gapFallback financials|
SA 50/C
F-Score: 7/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-69.9M · quality 50.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 3.4%, below the 5% threshold
Thesis & Journal · 2465.TWLocal privado en este navegador · Leadtek Research Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.4B

P/E

159.1x

↑

EV/EBITDA

55.6x

↑

ROE

3.4%

↓

Gross Margin

9.8%

↓

Debt/Equity

0.03

↓
52-Week Range$89
$48$94

TradingView lightweight chart

2465.TW price, volumen y niveles de valoración

Último $89.10Periodo +134.8%
Fair value: $89.10

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-5.8%

FCF CAGR

—

FCF margin

0.4%

FCF / Net income

0.54x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.44B · net income $36.5M · FCF $19.6M

2022-FY → 2025-FY

Gross margin

9.8%-1.6% pts

Operating margin

2.7%+5.4% pts

Net margin

0.8%+4.5% pts

FCF margin

0.4%+7.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$4.44B$4.44B$4.21B$4.28B$5.31B
Net Income$36.5M$36.5M$-441.2M$-159.7M$-195.8M
EBITDA$142.9M$142.9M$-190.9M$-43.4M$-126.2M
EPS——-5.26-2.53-3.32
Gross Margin9.8%9.8%8.0%14.7%11.4%
Operating Margin2.7%2.7%-5.8%-2.5%-2.7%
Net Margin0.8%0.8%-10.5%-3.7%-3.7%
Balance Sheet
Debt/Equity0.030.030.980.441.77
Current Ratio2.462.46———
Cash Flow
Free Cash Flow$19.6M$19.6M$-69.9M$-85.9M$-386.4M
Returns
ROE3.4%3.4%-75.5%-15.8%-38.4%
Valuation
P/E159.11159.11———
EV/EBITDA55.6255.62———
P/B7.707.7010.713.804.66
Growth & Yield
Revenue Growth5.4%5.4%-1.6%-19.5%—
EPS Growth——-107.9%23.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +42.8%

Total return

+42.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-5.26 → n/d

Residual

+42.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+42.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.